"CAPECITIME 500: Leading Capecitabine 500mg Treatment"

Mar 28, 2024

CAPECITIME 500 

Capecitabine lp (500mg)

Capecitabine lp (500mg) - CAPECITIME 500

Overview of CAPECITIME 500

CAPECITIME 500, containing the active ingredient Capecitabine in a 500mg dosage, is a widely used medication in the treatment of various types of cancer, including breast, colon, and rectal cancers. This oral chemotherapeutic agent is a prodrug, meaning it is converted into its active form within the body to effectively target and destroy cancer cells.

Mechanism of Action

  • Prodrug Conversion: CAPECITIME 500 is metabolized in the liver and tumor tissues to form 5-fluorouracil (5-FU), a potent chemotherapeutic agent.
  • Targeting Cancer Cells: The conversion to 5-FU primarily occurs in cancerous tissues, leading to a localized and potent anti-cancer effect.
  • Inhibiting DNA Synthesis: 5-FU interferes with DNA synthesis in cancer cells, preventing their replication and leading to cell death.

Key Benefits

  • Targeted Action: Preferential activation in cancer cells minimizes the impact on healthy tissues.
  • Oral Administration: Offers the convenience of at-home treatment, reducing the need for frequent hospital visits.
  • Broad Spectrum: Effective against a variety of cancer types, enhancing its utility in oncology.

Usage Guidelines

  • Dosage and Administration: Typically taken twice daily, within 30 minutes after a meal.
  • Treatment Duration: The duration and dosage may vary based on the cancer type, stage, and individual patient response.

Side Effects and Management

  • Common Side Effects: Include diarrhea, nausea, hand-foot syndrome, and fatigue.
  • Managing Side Effects: Regular monitoring and supportive care can mitigate adverse effects and improve quality of life during treatment.

Comparative Efficacy

  • Studies have shown that CAPECITIME 500 is as effective as intravenous formulations of 5-FU, with the added benefit of oral convenience and reduced hospital time.

Patient Experience

  • Quality of Life: Patients often report a better quality of life due to the oral route of administration and effective management of side effects.
  • Treatment Satisfaction: Many patients appreciate the effectiveness and convenience of CAPECITIME 500 in their cancer treatment regimen.

In conclusion, CAPECITIME 500 stands as a pivotal medication in the oncology arsenal, offering effective, targeted cancer treatment with the convenience of oral dosing. Its role in improving patient outcomes and quality of life continues to be supported by clinical research and patient experiences. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com     CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668   

  BUY NOW

SHARE WITH